These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 16165011)

  • 1. The double regulation of endothelial nitric oxide synthase by caveolae and caveolin: a paradox solved through the study of angiogenesis.
    Sbaa E; Frérart F; Feron O
    Trends Cardiovasc Med; 2005 Jul; 15(5):157-62. PubMed ID: 16165011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Caveolin-1 expression is critical for vascular endothelial growth factor-induced ischemic hindlimb collateralization and nitric oxide-mediated angiogenesis.
    Sonveaux P; Martinive P; DeWever J; Batova Z; Daneau G; Pelat M; Ghisdal P; Grégoire V; Dessy C; Balligand JL; Feron O
    Circ Res; 2004 Jul; 95(2):154-61. PubMed ID: 15205364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The calcium channel blocker amlodipine promotes the unclamping of eNOS from caveolin in endothelial cells.
    Batova S; DeWever J; Godfraind T; Balligand JL; Dessy C; Feron O
    Cardiovasc Res; 2006 Aug; 71(3):478-85. PubMed ID: 16814758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic association of nitric oxide downstream signaling molecules with endothelial caveolin-1 in rat aorta.
    Linder AE; McCluskey LP; Cole KR; Lanning KM; Webb RC
    J Pharmacol Exp Ther; 2005 Jul; 314(1):9-15. PubMed ID: 15778264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Caveolae, caveolin and control of vascular tone: nitric oxide (NO) and endothelium derived hyperpolarizing factor (EDHF) regulation.
    Rath G; Dessy C; Feron O
    J Physiol Pharmacol; 2009 Oct; 60 Suppl 4():105-9. PubMed ID: 20083858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caveolins and the regulation of endothelial nitric oxide synthase in the heart.
    Feron O; Balligand JL
    Cardiovasc Res; 2006 Mar; 69(4):788-97. PubMed ID: 16483868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caveolin, caveolae, and endothelial cell function.
    Frank PG; Woodman SE; Park DS; Lisanti MP
    Arterioscler Thromb Vasc Biol; 2003 Jul; 23(7):1161-8. PubMed ID: 12689915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of caveolin-1 in cardiovascular regulation.
    Rahman A; Swärd K
    Acta Physiol (Oxf); 2009 Feb; 195(2):231-45. PubMed ID: 18826501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caveolae and caveolins in the cardiovascular system.
    Gratton JP; Bernatchez P; Sessa WC
    Circ Res; 2004 Jun; 94(11):1408-17. PubMed ID: 15192036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel mechanism of endothelial nitric oxide synthase activation mediated by caveolae internalization in endothelial cells.
    Maniatis NA; Brovkovych V; Allen SE; John TA; Shajahan AN; Tiruppathi C; Vogel SM; Skidgel RA; Malik AB; Minshall RD
    Circ Res; 2006 Oct; 99(8):870-7. PubMed ID: 16973909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating cardiovascular disease risk factors and signaling in endothelial cell caveolae.
    Mineo C; Shaul PW
    Cardiovasc Res; 2006 Apr; 70(1):31-41. PubMed ID: 16540099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of P104L mutant caveolin-3 in mice develops hypertrophic cardiomyopathy with enhanced contractility in association with increased endothelial nitric oxide synthase activity.
    Ohsawa Y; Toko H; Katsura M; Morimoto K; Yamada H; Ichikawa Y; Murakami T; Ohkuma S; Komuro I; Sunada Y
    Hum Mol Genet; 2004 Jan; 13(2):151-7. PubMed ID: 14645200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamin mediates caveolar sequestration of muscarinic cholinergic receptors and alteration in NO signaling.
    Dessy C; Kelly RA; Balligand JL; Feron O
    EMBO J; 2000 Aug; 19(16):4272-80. PubMed ID: 10944110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caveolin-1 interacts and cooperates with the transforming growth factor-beta type I receptor ALK1 in endothelial caveolae.
    Santibanez JF; Blanco FJ; Garrido-Martin EM; Sanz-Rodriguez F; del Pozo MA; Bernabeu C
    Cardiovasc Res; 2008 Mar; 77(4):791-9. PubMed ID: 18065769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colocalization prostacyclin (PGI2) synthase--caveolin-1 in endothelial cells and new roles for PGI2 in angiogenesis.
    Spisni E; Griffoni C; Santi S; Riccio M; Marulli R; Bartolini G; Toni M; Ullrich V; Tomasi V
    Exp Cell Res; 2001 May; 266(1):31-43. PubMed ID: 11339822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eicosapentaenoic acid modifies lipid composition in caveolae and induces translocation of endothelial nitric oxide synthase.
    Li Q; Zhang Q; Wang M; Zhao S; Ma J; Luo N; Li N; Li Y; Xu G; Li J
    Biochimie; 2007 Jan; 89(1):169-77. PubMed ID: 17125900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new paradigm: calcium independent and caveolae internalization dependent release of nitric oxide by the endothelial nitric oxide synthase.
    Bkaily G; D'Orleans-Juste P; Jacques D
    Circ Res; 2006 Oct; 99(8):793-4. PubMed ID: 17038647
    [No Abstract]   [Full Text] [Related]  

  • 18. Docosahexaenoic acid affects endothelial nitric oxide synthase in caveolae.
    Li Q; Zhang Q; Wang M; Liu F; Zhao S; Ma J; Luo N; Li N; Li Y; Xu G; Li J
    Arch Biochem Biophys; 2007 Oct; 466(2):250-9. PubMed ID: 17662956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do the signalling proteins for angiogenesis exist as a modular complex? The case for the angosome.
    Hoffman R
    Med Hypotheses; 2004; 63(4):675-80. PubMed ID: 15325015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of TGF-beta1 signaling by eNOS gene transfer improves ventricular remodeling after myocardial infarction through angiogenesis and reduction of apoptosis.
    Chen LL; Yin H; Huang J
    Cardiovasc Pathol; 2007; 16(4):221-30. PubMed ID: 17637430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.